Effects of 5-fluorouracil chemotherapy on fatigue: Role of MCP-1

Akagi, 2008, Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBPbeta-deficient hematopoietic cells, Blood, 111, 2999, 10.1182/blood-2007-04-087213 Balkwill, 2012, Cancer-related inflammation: common themes and therapeutic opportunities, Semin. Cancer Biol., 22, 33, 10.1016/j.semcancer.2011.12.005 Barclay, 2001, A rapid assay for mitochondrial DNA damage and respiratory chain inhibition in the yeast Saccharomyces cerevisiae, Environ. Mol. Mutagen., 38, 153, 10.1002/em.1066 Birgegård, 2005, Cancer-related anemia: pathogenesis, prevalence and treatment, Oncology, 68, 3, 10.1159/000083128 Bower, 2011, Fatigue and gene expression in human leukocytes: increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue, Brain Behav. Immun., 25, 147, 10.1016/j.bbi.2010.09.010 Carmichael, 2006, Role of brain IL-1beta on fatigue after exercise-induced muscle damage, Am. J. Physiol. Regul. Integr. Comp. Physiol., 291, R1344, 10.1152/ajpregu.00141.2006 Chang, 2012, 5-fluorouracil induced intestinal mucositis via nuclear factor-κb activation by transcriptomic analysis and in vivo bioluminescence imaging, PLoS One, 7, e31808, 10.1371/journal.pone.0031808 Curt, 2000, Impact of fatigue on quality of life in oncology patients, Semin. Hematol., 37, 14, 10.1016/S0037-1963(00)90063-5 Dantzer, 2012, Translational approaches to treatment-induced symptoms in cancer patients, Nat. Rev. Clin. Oncol., 9, 414, 10.1038/nrclinonc.2012.88 Davis, 2007, Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage, Am. J. Physiol. Regul. Integr. Comp. Physiol., 292, R2168, 10.1152/ajpregu.00858.2006 Elsea, 2008, Inhibition of p38 MAPK suppresses inflammatory cytokine induction by etoposide, 5-fluorouracil, and doxorubicin without affecting tumoricidal activity, PLoS One, 3, e2355, 10.1371/journal.pone.0002355 Goede, 1999, Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1, Int. J. Cancer, 82, 765, 10.1002/(SICI)1097-0215(19990827)82:5<765::AID-IJC23>3.0.CO;2-F Han, 2008, Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system, J. Biol., 7, 12, 10.1186/jbiol69 Hilton, 2009, Mutational inhibition of c-Myb or p300 ameliorates treatment-induced thrombocytopenia, Blood, 133, 5599, 10.1182/blood-2008-12-195255 Jager, 2008, The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator?, Eur. J. Cancer, 44, 175, 10.1016/j.ejca.2007.11.023 Jean-Pierre, 2007, Assessment of cancer-related fatigue: implications for clinical diagnosis and treatment, Oncologist, 12, 11, 10.1634/theoncologist.12-S1-11 Kornblith, 2011, Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907, J. Clin. Oncol., 29, 1022, 10.1200/JCO.2010.29.9859 Logan, 2008, Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs, Cancer Biol. Ther., 7, 1139, 10.4161/cbt.7.7.6207 Macquart-Moulin, 1999, Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization, Cancer, 85, 2190, 10.1002/(SICI)1097-0142(19990515)85:10<2190::AID-CNCR13>3.0.CO;2-P Maes, 2012, Nflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression, Psychother Psychosom, 81, 286, 10.1159/000336803 McClellan, J.L., Davis, J.M., Steiner, J.L., Enos, R.T., Jung, S.H., Carson, J.A., Pena, M.M., Carnevale, K.A., Berger, F.G., Murphy, E.A., 2012. Linking tumor associated macrophages, inflammation, and intestinal tumorigenesis: Role of MCP-1. Am. J. Physiol. Gastrointest. Liver Physiol. Sep 27 (Epub ahead of print). Mock, 2001, Fatigue management: evidence and guidelines for practice, Cancer, 92, 1699, 10.1002/1097-0142(20010915)92:6+<1699::AID-CNCR1500>3.0.CO;2-9 Morrow, 2002, Fatigue associated with cancer and its treatment, Support. Care Cancer, 10, 389, 10.1007/s005200100293 Ottenweller, 1998, Mouse running activity is lowered by Brucella abortus treatment: a potential model to studychronic fatigue, Physiol. Behav., 63, 795, 10.1016/S0031-9384(97)00539-8 Pusztai, 2004, Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy, Cytokine, 25, 94, 10.1016/j.cyto.2003.10.004 Ray, 2011, Development of a mouse model for assessing fatigue during chemotherapy, Comp. Med., 61, 119 Ryan, 2007, Mechanisms of cancer-related fatigue, Oncologist, 12, 22, 10.1634/theoncologist.12-S1-22 Soares, 2010, Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice, Cancer Chemother. Pharmacol., 14 Soria, 2011, Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition, BMC Cancer, 12, 130, 10.1186/1471-2407-11-130 Steiner, 2012, Importance of chemokine (CC-motif) ligand 2 in breast cancer, Int. J. Biol. Markers, 31 Thompson, 2008, MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult, J. Neuroinflammation, 15, 35, 10.1186/1742-2094-5-35 Wang, 2010, Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy, Brain Behav Immun., 24, 968, 10.1016/j.bbi.2010.03.009 Wood, 2006, The cancer chemotherapy drug etoposide (VP-16) induces proinflammatory cytokine production and sickness behavior-like symptoms in a mouse model of cancer chemotherapy-related symptoms, Biol. Res. Nurs., 8, 157, 10.1177/1099800406290932